Sarah Gough - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Sarah Gough's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists todaySarah Gough
Verified
LA Producer, Sky News
Los Angeles
Beats
World NewsU.S. Politics (Gen Z Voter Trends) European Politics International Politics EU News
Common bleed-lead narrative
Content
By Haoran Zhu, Masako Narita, Sarah Gough Verified, Lars Zender, Sarah Aitken, Matthew Hoare, Camino Bermejo-Rodriguez, Aleksandra T. Janowska| Nature Verified AbstractOncogenic RAS-induced senescence (OIS) is an autonomous tumour suppressor mechanism associated with premalignancy1,2. Achieving this phenotype typically requires a high level of oncogenic stress, yet the phenotype provoked by lower oncogenic dosage remains unclear. Here we develop oncogenic RAS dose-escalation models in vitro and in vivo, revealing a RAS dose-driven non-linear continuum of downstream phenotypes.
By Sarah Gough Verified| MSN UK Verified Microsoft Cares About Your PrivacyMicrosoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing will personalise the content and ads that you see. You can select ‘I Accept’ to consent to these uses or click on ‘Manage preferences’ to review your options and exercise your right to object to Legitimate Interest where used.
By Haoran Zhu, Masako Narita, Sarah Gough Verified, Lars Zender, Sarah Aitken, Matthew Hoare, Camino Bermejo-Rodriguez, Aleksandra T. Janowska| Nature Verified AbstractOncogenic RAS-induced senescence (OIS) is an autonomous tumour suppressor mechanism associated with premalignancy1,2. Achieving this phenotype typically requires a high level of oncogenic stress, yet the phenotype provoked by lower oncogenic dosage remains unclear. Here we develop oncogenic RAS dose-escalation models in vitro and in vivo, revealing a RAS dose-driven non-linear continuum of downstream phenotypes.
Company Info
Sky News
Sky News is a British free-to-air television news channel that provides 24-hour news coverage. Launched on February 5, 1989, it was the UK's first continuous news broadcaster, offering real-time updates on breaking news, political events, and global happenings. The channel is known for its high-definition broadcasting, which began in 2006, enhancing the viewing experience for audiences. Sky News operates in over 120 countries and offers various digital platforms, including live streaming and mobile apps, to complement its television broadcasts. The channel features specialized programming that includes political analysis, investigative journalism, and live event coverage. It relies on sponsorships for funding rather than traditional advertising, maintaining a commitment to impartiality and journalistic quality.
England, United Kingdom